cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity (Q34192806)

31 July 2017

cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity (English)

1 reference

31 July 2017

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity (English)

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

27 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

27 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

27 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

27 December 2023

author name string

Kerry Klussman

5

1 reference

31 July 2017

Ron DeBlanc

9

1 reference

31 July 2017

Che-Leung Law

11

1 reference

31 July 2017

Joseph A. Francisco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Charles G. Cerveny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Damon L. Meyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Bruce J. Mixan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Dana F. Chace

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Starr X. Rejniak

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Kristine A. Gordon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Brian E. Toki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Svetlana O. Doronina

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Clay B. Siegall

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Peter D. Senter

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

Alan F. Wahl

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714494

27 December 2023

language of work or name

English

0 references

publication date

24 April 2003

1 reference

full work available at URL

31 July 2017

published in

Blood

1 reference

31 July 2017

102

1 reference

31 July 2017

1458-1465

1 reference

31 July 2017

4

1 reference

Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1.

31 July 2017

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

CD30 in normal and neoplastic cells.

27 December 2023

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Expression of the CD30 antigen in non-lymphoid tissues and cells

27 December 2023

3

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role

27 December 2023

4

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis

27 December 2023

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): immunohistological evidence

27 December 2023

7

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation

27 December 2023

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Recombinant immunotoxins for the treatment of Hodgkin's disease (Review).

27 December 2023

9

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Toxin-labeled monoclonal antibodies

27 December 2023

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma

27 December 2023

14

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma

27 December 2023

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains

27 December 2023

17

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Nitric oxide inhibits peroxide-mediated endothelial toxicity.

27 December 2023

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin

27 December 2023

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

27 December 2023

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.

27 December 2023

23

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Toxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance

27 December 2023

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

New approaches to antibody therapy

27 December 2023

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

27 December 2023

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors

27 December 2023

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Eradication of large colon tumor xenografts by targeted delivery of maytansinoids

27 December 2023

28

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker

27 December 2023

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

27 December 2023

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activity

27 December 2023

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

27 December 2023

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0039

27 December 2023

Identifiers

1 reference

release_z6v2r25kjbaw3mbyglqs7vgzxe

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z6v2r25kjbaw3mbyglqs7vgzxe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference